What is chronic inflammatory demyeliating polyneuropathy and what are its life-threatening consequences
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), a debilitating neurological disease that can cause inflammation throughout the body. Rituximab is being used more often for patients that have moderate to severe symptoms associated with CIDP. This is because it has been shown to alleviate the pain associated with CIDP in half of the patients that have been treated with it. The other half of patients saw a marked improvement when it was added into their treatment. Inflammatory Demyelinating Polyneuropathy , better known as IDP is a chronic, progressive ailment that can have life-threatening consequences. Its name was derived from the inflammation of the peripheral nerves, where the affliction occurs. The symptoms are extremely painful and include loss of feeling in the extremities, weakness, numbness, and even paralysis of the lower limbs. This disease is not curable and the only recourse is to wait and see if the disease does not affect the patient in other ways. Inflammatory D...